AGAMMAGLOBULINEMIA

Clinical trials for AGAMMAGLOBULINEMIA explained in plain language.

Never miss a new study

Get alerted when new AGAMMAGLOBULINEMIA trials appear

Sign up with your email to follow new studies for AGAMMAGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New treatment trial aims to protect people with rare immune deficiencies

Disease control Recruiting now

This study is testing a new immunoglobulin product called V-IMMUNE® for people with primary immunodeficiency (PID), a condition where the body cannot make enough antibodies to fight infections. About 50 participants, aged 2 and older who are already receiving similar treatments, …

Matched conditions: AGAMMAGLOBULINEMIA

Phase: PHASE3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

AGAMMAGLOBULINEMIA

Get alerted when new AGAMMAGLOBULINEMIA trials appear

New treatment trial aims to protect people with rare immune deficiencies